Search

everythinglearnresearchcommunity

for

Search:↓

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Certain Dibenzo derivatives may help treat prostate cancer.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Testosterone affects vascular cells directly without converting to estradiol.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Blocking androgens at birth reduces sexual motivation in male rats.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

In vitro bioassays are better than traditional methods for measuring androgen activity but aren't ready for routine use yet.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Androgens and estrogens are crucial for male reproductive health, affecting hormone levels and tissue function.

Dutasteride and finasteride affect different cell types differently.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Hidradenitis suppurativa improves with antiandrogen therapy.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

5alpha-reductase 2 is crucial for proper male brain development and sexual differentiation.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.